Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials


Evaluation of the Effect of Ketamine on Neurological Activity as Measured by Quantitative EEG


To see complete record on clinicaltrials.gov, please visit this link

Id: NCT05095792

Organisation Name: Entheon Biomedical Corp.

Overal Status: Recruiting

Start Date: November 9, 2021

Last Update: November 10, 2021

Lead Sponsor: Entheon Biomedical Corp.

Brief Summary: This observational study will allow data to be collected to demonstrate changes in brain activity following administration of standard of care (SOC) Ketamine. By comparing genetic markers across participants, data on impact of genetic markers and response to Ketamine will also be analysed. This data will contribute to the design of future studies utilizing Ketamine for various psychiatric disorders. This study will focus on treatment-resistant Major Depressive Disorder (MDD).

Conditions:
  • Treatment-resistant Depression


Total execution time in seconds: 0.34090399742126